The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 03, 2015

Filed:

Dec. 20, 2011
Applicants:

Lorenzo Mangolini, Minneapolis, MN (US);

Uwe Kortshagen, Roseville, MN (US);

Rebecca J. Anthony, Minneapolis, MN (US);

David Jurbergs, Austin, TX (US);

Xuegeng LI, Sunnyvale, CA (US);

Elena Rogojina, Los Altos, CA (US);

Inventors:

Lorenzo Mangolini, Minneapolis, MN (US);

Uwe Kortshagen, Roseville, MN (US);

Rebecca J. Anthony, Minneapolis, MN (US);

David Jurbergs, Austin, TX (US);

Xuegeng Li, Sunnyvale, CA (US);

Elena Rogojina, Los Altos, CA (US);

Assignees:

Regents of the University of Minnesota, Minneapolis, MN (US);

Innovalight, Inc., Sunnyvale, CA (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
B82Y 40/00 (2011.01); C23C 16/00 (2006.01); B01J 19/08 (2006.01); C01B 33/02 (2006.01);
U.S. Cl.
CPC ...
B01J 19/088 (2013.01); C01B 33/02 (2013.01); B01J 2219/0809 (2013.01); B01J 2219/0835 (2013.01); B01J 2219/0847 (2013.01); B01J 2219/0849 (2013.01); B01J 2219/0869 (2013.01); B01J 2219/0875 (2013.01); B01J 2219/0886 (2013.01); B01J 2219/0896 (2013.01); Y10S 977/773 (2013.01);
Abstract

An apparatus for producing grafted Group IV nanoparticles is provided and includes a source of Group IV nanoparticles. A chamber is configured to carry the nanoparticles in a gas phase and has an inlet and an exit. The inlet configured to couple to an organic molecule source which is configured to provide organic molecules to the chamber. A plasma source is arranged to generate a plasma. The plasma causes the organic molecules to break down and/or activate in the chamber and bond to the nanoparticles. A method of producing grafted Group IV nanoparticles is also provided and includes receiving Group IV nanoparticles in a gas phase, creating a plasma with the nanoparticles, and allowing the organic molecules to break down and/or become activated in the plasma and bond with the nanoparticles.


Find Patent Forward Citations

Loading…